# Disruption of Regulatory T Lymphocytes by B Lymphocytes in Type 1 Diabetes

> **NIH NIH F30** · VANDERBILT UNIVERSITY · 2020 · $30,229

## Abstract

Summary
The training platform in this proposal examines how B lymphocytes disrupt Regulatory T Lymphocytes (Tregs)
in Type 1 Diabetes (T1D). T1D is an incurable autoimmune disease with significant morbidity and mortality.
Although cytotoxic T lymphocytes are directly responsible for the autoimmune destruction of pancreatic beta
cells, Tregs fail to suppress this inappropriate immune response. The exact defect in Tregs that leads to failure
to protect the pancreatic islet is unknown. During development from precursor T lymphocytes, nascent Tregs in
the thymus are exposed to antigen by antigen-presenting cells, including thymic B lymphocytes. In my
preliminary studies, I show that the presence of B lymphocytes leads to decreased protective islet-reactive
Tregs in the mouse model of T1D, the NOD mouse. Our lab has also shown that a B lymphocyte deficient
NOD mouse can be tolerized to islet transplant, and post-transplant, has increased numbers of Tregs. These
studies indicate the important biologic impact of B lymphocytes on immune regulation in T1D and reveal that B
lymphocytes are the critical barrier preventing inducible tolerance in T1D. I hypothesize that thymic B
lymphocytes interfere with naïve T cell development, such that both thymically-derived Tregs and naïve T cells
that might later go on to become peripherally-induced Tregs are unable to appropriately protect the islet. I will
dissect the mechanism behind how B lymphocytes interfere with T cell development by using fetal thymic
organ culture and mass cytometry to visualize direct effects of B lymphocytes on Tregs (Aim 1). I will evaluate
the timing in which a B lymphocyte is able to permanently impact T cell development by using two-photon
microscopy and transgenic antigen-specific mouse models to elucidate whether a T cell is forever changed by
interaction with a thymic B lymphocyte (Aim 2). Through this fellowship application, I will demonstrate the
mechanisms behind Treg dysregulation, which will allow for novel therapeutic strategies for patients with T1D.
The endocrinology and immunology I learn as a graduate student underlies the research I will dedicate my
career to: investigating Type 1 Diabetes and Systemic Lupus Erythematosus in pregnancy. In addition to the
scientific training, I will also be supported by my newly formed career mentoring committee composed of
experts in research relating to pregnancy and in the development of proceduralist-scientists. Through this
integrated training program, I will develop a foundation for my development as a basic scientist that will serve
me as I pursue a career as an obstetrician scientist.

## Key facts

- **NIH application ID:** 9996320
- **Project number:** 5F30DK121438-02
- **Recipient organization:** VANDERBILT UNIVERSITY
- **Principal Investigator:** Kelsey McNew
- **Activity code:** F30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $30,229
- **Award type:** 5
- **Project period:** 2019-08-01 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9996320

## Citation

> US National Institutes of Health, RePORTER application 9996320, Disruption of Regulatory T Lymphocytes by B Lymphocytes in Type 1 Diabetes (5F30DK121438-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9996320. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*